Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
CN |
|
Severstal' PAO
OTC:SVJTY
|
RU |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
CN |
Balance Sheet
Balance Sheet Decomposition
Jiangsu Hengrui Pharmaceuticals Co Ltd
Jiangsu Hengrui Pharmaceuticals Co Ltd
Balance Sheet
Jiangsu Hengrui Pharmaceuticals Co Ltd
| Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
119
|
128
|
363
|
431
|
566
|
573
|
385
|
707
|
995
|
949
|
1 329
|
2 169
|
3 449
|
5 133
|
4 912
|
4 262
|
3 866
|
5 031
|
10 731
|
13 607
|
15 110
|
20 746
|
24 802
|
40 855
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
13 120
|
14 537
|
20 272
|
24 239
|
40 855
|
|
| Cash Equivalents |
119
|
128
|
363
|
431
|
566
|
573
|
385
|
707
|
995
|
949
|
1 329
|
2 169
|
3 449
|
5 133
|
4 912
|
4 262
|
3 866
|
5 031
|
10 731
|
487
|
573
|
475
|
563
|
0
|
|
| Short-Term Investments |
83
|
73
|
0
|
0
|
11
|
271
|
80
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1 594
|
4 550
|
7 063
|
8 607
|
5 628
|
5 090
|
2 760
|
99
|
273
|
114
|
|
| Total Receivables |
314
|
384
|
326
|
291
|
265
|
556
|
889
|
1 234
|
1 726
|
2 173
|
2 492
|
2 609
|
2 987
|
3 472
|
3 795
|
4 531
|
5 517
|
6 462
|
9 277
|
7 659
|
9 050
|
6 681
|
6 422
|
6 319
|
|
| Accounts Receivables |
215
|
226
|
157
|
155
|
141
|
439
|
612
|
855
|
1 162
|
1 251
|
1 443
|
1 560
|
1 796
|
2 092
|
2 325
|
3 189
|
3 773
|
4 906
|
5 074
|
4 633
|
5 891
|
5 194
|
4 915
|
5 147
|
|
| Other Receivables |
99
|
158
|
169
|
136
|
124
|
117
|
277
|
379
|
564
|
922
|
1 049
|
1 049
|
1 191
|
1 380
|
1 470
|
1 342
|
1 744
|
1 556
|
4 203
|
3 027
|
3 159
|
1 487
|
1 507
|
1 173
|
|
| Inventory |
96
|
113
|
63
|
69
|
98
|
120
|
162
|
177
|
176
|
300
|
338
|
430
|
551
|
523
|
637
|
790
|
1 031
|
1 607
|
1 778
|
2 403
|
2 451
|
2 314
|
2 417
|
2 878
|
|
| Other Current Assets |
17
|
37
|
6
|
10
|
5
|
13
|
36
|
30
|
94
|
309
|
355
|
204
|
213
|
251
|
455
|
335
|
593
|
604
|
635
|
1 428
|
1 562
|
1 447
|
1 400
|
1 324
|
|
| Total Current Assets |
628
|
736
|
759
|
801
|
945
|
1 532
|
1 553
|
2 148
|
2 991
|
3 731
|
4 514
|
5 412
|
7 200
|
9 378
|
11 393
|
14 469
|
18 069
|
22 311
|
28 050
|
30 188
|
30 934
|
31 287
|
35 315
|
51 490
|
|
| PP&E Net |
549
|
692
|
491
|
480
|
480
|
472
|
515
|
559
|
761
|
984
|
1 269
|
1 564
|
1 624
|
1 770
|
2 474
|
3 079
|
3 686
|
4 075
|
4 585
|
6 725
|
6 999
|
6 964
|
7 407
|
8 519
|
|
| PP&E Gross |
549
|
692
|
491
|
480
|
480
|
472
|
515
|
559
|
761
|
984
|
1 269
|
1 564
|
1 624
|
1 770
|
2 474
|
3 079
|
3 686
|
4 075
|
4 585
|
6 725
|
6 999
|
6 964
|
7 407
|
8 519
|
|
| Accumulated Depreciation |
135
|
179
|
94
|
137
|
188
|
240
|
296
|
357
|
422
|
516
|
640
|
784
|
983
|
1 111
|
1 344
|
1 636
|
1 996
|
2 574
|
2 924
|
3 382
|
3 903
|
4 425
|
5 052
|
5 687
|
|
| Intangible Assets |
14
|
14
|
1
|
0
|
29
|
30
|
29
|
50
|
52
|
51
|
67
|
203
|
200
|
196
|
285
|
279
|
273
|
350
|
341
|
702
|
2 201
|
3 376
|
5 030
|
6 834
|
|
| Long-Term Investments |
1
|
1
|
4
|
4
|
4
|
4
|
103
|
192
|
41
|
5
|
5
|
5
|
5
|
79
|
81
|
118
|
156
|
599
|
1 502
|
1 001
|
1 508
|
1 451
|
1 732
|
2 030
|
|
| Other Long-Term Assets |
12
|
8
|
0
|
0
|
10
|
20
|
54
|
49
|
50
|
46
|
37
|
37
|
58
|
73
|
97
|
95
|
177
|
221
|
251
|
651
|
729
|
706
|
652
|
993
|
|
| Total Assets |
1 205
N/A
|
1 451
+20%
|
1 255
-14%
|
1 285
+2%
|
1 468
+14%
|
2 058
+40%
|
2 254
+10%
|
2 999
+33%
|
3 896
+30%
|
4 818
+24%
|
5 893
+22%
|
7 220
+23%
|
9 087
+26%
|
11 497
+27%
|
14 330
+25%
|
18 039
+26%
|
22 361
+24%
|
27 556
+23%
|
34 730
+26%
|
39 266
+13%
|
42 371
+8%
|
43 785
+3%
|
50 136
+15%
|
69 867
+39%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
50
|
64
|
66
|
58
|
46
|
93
|
132
|
139
|
197
|
200
|
220
|
282
|
396
|
492
|
755
|
734
|
1 381
|
1 289
|
1 326
|
1 787
|
1 487
|
1 510
|
1 967
|
2 270
|
|
| Accrued Liabilities |
56
|
78
|
49
|
41
|
72
|
130
|
78
|
126
|
119
|
107
|
0
|
78
|
99
|
91
|
233
|
357
|
66
|
185
|
139
|
181
|
110
|
152
|
165
|
138
|
|
| Short-Term Debt |
121
|
232
|
59
|
0
|
0
|
113
|
0
|
0
|
0
|
0
|
0
|
8
|
23
|
14
|
85
|
59
|
113
|
315
|
408
|
563
|
1 709
|
170
|
251
|
69
|
|
| Current Portion of Long-Term Debt |
50
|
39
|
20
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
0
|
10
|
0
|
10
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
41
|
31
|
|
| Other Current Liabilities |
29
|
22
|
43
|
24
|
34
|
41
|
20
|
60
|
85
|
113
|
220
|
107
|
333
|
446
|
292
|
900
|
934
|
683
|
1 899
|
871
|
334
|
721
|
1 209
|
3 861
|
|
| Total Current Liabilities |
305
|
433
|
237
|
123
|
153
|
377
|
230
|
324
|
401
|
429
|
440
|
485
|
851
|
1 053
|
1 365
|
2 050
|
2 494
|
2 473
|
3 772
|
3 402
|
3 639
|
2 554
|
3 634
|
6 369
|
|
| Long-Term Debt |
90
|
114
|
20
|
48
|
48
|
0
|
0
|
10
|
20
|
10
|
10
|
10
|
10
|
0
|
0
|
0
|
0
|
0
|
0
|
152
|
99
|
75
|
69
|
43
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
25
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
24
|
30
|
25
|
100
|
84
|
117
|
117
|
|
| Minority Interest |
18
|
17
|
14
|
13
|
11
|
17
|
30
|
57
|
87
|
154
|
228
|
299
|
355
|
426
|
486
|
575
|
70
|
162
|
283
|
569
|
589
|
567
|
570
|
525
|
|
| Other Liabilities |
0
|
0
|
0
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
69
|
72
|
86
|
91
|
46
|
70
|
122
|
141
|
117
|
119
|
39
|
226
|
1 541
|
|
| Total Liabilities |
412
N/A
|
564
+37%
|
272
-52%
|
190
-30%
|
212
+12%
|
420
+98%
|
260
-38%
|
391
+50%
|
508
+30%
|
594
+17%
|
678
+14%
|
863
+27%
|
1 289
+49%
|
1 565
+21%
|
1 942
+24%
|
2 672
+38%
|
2 633
-1%
|
2 781
+6%
|
4 225
+52%
|
4 263
+1%
|
4 547
+7%
|
3 319
-27%
|
4 616
+39%
|
8 595
+86%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
255
|
255
|
255
|
255
|
332
|
431
|
517
|
621
|
749
|
1 124
|
1 237
|
1 360
|
1 505
|
1 956
|
2 347
|
2 833
|
3 686
|
4 423
|
5 332
|
6 396
|
6 379
|
6 379
|
6 379
|
6 637
|
|
| Retained Earnings |
142
|
237
|
283
|
389
|
606
|
869
|
1 162
|
1 672
|
2 210
|
2 787
|
3 651
|
4 667
|
5 924
|
7 644
|
9 646
|
12 076
|
15 207
|
19 103
|
23 530
|
25 928
|
28 819
|
32 102
|
37 164
|
43 601
|
|
| Additional Paid In Capital |
395
|
395
|
395
|
395
|
318
|
338
|
316
|
316
|
429
|
314
|
328
|
332
|
508
|
420
|
438
|
987
|
1 479
|
1 663
|
3 143
|
3 356
|
3 020
|
3 058
|
3 188
|
12 935
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
136
|
88
|
43
|
528
|
634
|
420
|
1 495
|
665
|
398
|
1 092
|
1 229
|
1 929
|
|
| Other Equity |
0
|
0
|
51
|
56
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
0
|
0
|
10
|
7
|
5
|
12
|
3
|
19
|
17
|
28
|
|
| Total Equity |
792
N/A
|
887
+12%
|
984
+11%
|
1 095
+11%
|
1 256
+15%
|
1 638
+30%
|
1 994
+22%
|
2 608
+31%
|
3 387
+30%
|
4 224
+25%
|
5 214
+23%
|
6 357
+22%
|
7 798
+23%
|
9 931
+27%
|
12 388
+25%
|
15 368
+24%
|
19 728
+28%
|
24 775
+26%
|
30 504
+23%
|
35 003
+15%
|
37 824
+8%
|
40 466
+7%
|
45 520
+12%
|
61 272
+35%
|
|
| Total Liabilities & Equity |
1 205
N/A
|
1 451
+20%
|
1 255
-14%
|
1 285
+2%
|
1 468
+14%
|
2 058
+40%
|
2 254
+10%
|
2 999
+33%
|
3 896
+30%
|
4 818
+24%
|
5 893
+22%
|
7 220
+23%
|
9 087
+26%
|
11 497
+27%
|
14 330
+25%
|
18 039
+26%
|
22 361
+24%
|
27 556
+23%
|
34 730
+26%
|
39 266
+13%
|
42 371
+8%
|
43 785
+3%
|
50 136
+15%
|
69 867
+39%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
6 254
|
6 254
|
6 254
|
6 254
|
6 254
|
6 254
|
6 254
|
6 254
|
6 292
|
6 292
|
6 292
|
6 292
|
4 840
|
6 305
|
6 316
|
6 318
|
6 328
|
6 350
|
6 356
|
6 382
|
6 370
|
6 355
|
6 379
|
6 637
|
|